Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals (NASDAQ: TARS) has announced its participation in three upcoming investor conferences in May 2025:
- Bank of America Securities 2025 Health Care Conference on May 13th at 6:40 PM ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference on May 20th at 3:00 PM ET
- Stifel Virtual Ophthalmology Forum on May 27th at 10:30 AM ET
Live webcasts will be available on the events section of Tarsus's website, with replays accessible within 48 hours and archived for a limited time.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha annunciato la sua partecipazione a tre conferenze per investitori previste per maggio 2025:
- Bank of America Securities 2025 Health Care Conference il 13 maggio alle 18:40 ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference il 20 maggio alle 15:00 ET
- Stifel Virtual Ophthalmology Forum il 27 maggio alle 10:30 ET
Le dirette streaming saranno disponibili nella sezione eventi del sito web di Tarsus, con le registrazioni accessibili entro 48 ore e archiviate per un periodo limitato.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha anunciado su participaci贸n en tres pr贸ximas conferencias para inversores en mayo de 2025:
- Bank of America Securities 2025 Health Care Conference el 13 de mayo a las 6:40 PM ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference el 20 de mayo a las 3:00 PM ET
- Stifel Virtual Ophthalmology Forum el 27 de mayo a las 10:30 AM ET
Las transmisiones en vivo estar谩n disponibles en la secci贸n de eventos del sitio web de Tarsus, con repeticiones accesibles dentro de las 48 horas y archivadas por tiempo limitado.
Tarsus Pharmaceuticals (NASDAQ: TARS)電� 2025雲� 5鞗旍棎 鞓堨爼霅� 靹� 臧�歆� 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟:
- Bank of America Securities 2025 Health Care Conference 5鞗� 13鞚� 鞓ろ泟 6:40 ET
- H.C. Wainwright & Co. 鞝�3須� 鞐半 BioConnect Nasdaq 韴瀽鞛� 旎嵓霟办姢 5鞗� 20鞚� 鞓ろ泟 3:00 ET
- Stifel Virtual Ophthalmology Forum 5鞗� 27鞚� 鞓れ爠 10:30 ET
霛检澊敫� 鞗轨簮鞀ろ姼電� Tarsus 鞗轨偓鞚错姼鞚� 鞚措菠韸� 靹轨厴鞐愳劀 鞝滉车霅橂┌, 鞛儩鞚� 48鞁滉皠 鞚措偞鞐� 臧�電ロ晿瓿� 鞝滍暅霅� 旮瓣皠 霃欖晥 鞎勳勾鞚措笇霅╇媹雼�.
Tarsus Pharmaceuticals (NASDAQ : TARS) a annonc茅 sa participation 脿 trois prochaines conf茅rences pour investisseurs en mai 2025 :
- Bank of America Securities 2025 Health Care Conference le 13 mai 脿 18h40 ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference le 20 mai 脿 15h00 ET
- Stifel Virtual Ophthalmology Forum le 27 mai 脿 10h30 ET
Des webcasts en direct seront disponibles dans la section 茅v茅nements du site de Tarsus, avec des rediffusions accessibles dans les 48 heures et archiv茅es pour une dur茅e limit茅e.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im Mai 2025 angek眉ndigt:
- Bank of America Securities 2025 Health Care Conference am 13. Mai um 18:40 Uhr ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference am 20. Mai um 15:00 Uhr ET
- Stifel Virtual Ophthalmology Forum am 27. Mai um 10:30 Uhr ET
Live-Webcasts werden im Veranstaltungsbereich der Tarsus-Website verf眉gbar sein, mit Wiederholungen, die innerhalb von 48 Stunden zug盲nglich sind und f眉r eine begrenzte Zeit archiviert werden.
- None.
- None.
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences:
- Bank of America Securities 2025 Health Care Conference on Tuesday, May 13th, at 3:40 p.m. PT / 6:40 p.m. ET
- H.C. Wainwright & Co. 3rd Annual BioConnect Nasdaq Investor Conference on Tuesday, May 20th, at 12:00 p.m. PT / 3:00 p.m. ET
- Stifel Virtual Ophthalmology Forum on Tuesday, May 27th, at 7:30 a.m. PT / 10:30 a.m. ET
Live webcasts and additional information can be accessed on the events section of the Tarsus . Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
FAQ
What investor conferences will Tarsus Pharmaceuticals (TARS) attend in May 2025?
When is Tarsus Pharmaceuticals (TARS) presenting at the Bank of America Securities Health Care Conference 2025?
How can investors access Tarsus Pharmaceuticals' (TARS) conference presentations?
What time is Tarsus (TARS) presenting at the Stifel Virtual Ophthalmology Forum?
